{
    "Trade/Device Name(s)": [
        "Psychemedics Homogeneous Enzyme Immunoassay for Opiates in Hair",
        "Psychemedics Homogeneous Enzyme Immunoassay for Oxycodone in Hair"
    ],
    "Submitter Information": "Psychemedics Corporation",
    "510(k) Number": "K201326",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111926",
        "K123799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "July 27, 2021",
    "Summary Letter Received Date": "January 6, 2021",
    "Submission Date": "January 5, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Opiates",
        "Oxycodone",
        "Morphine",
        "Codeine",
        "6-Acetylmorphine",
        "Hydrocodone",
        "Hydromorphone",
        "Buprenorphine",
        "Oxymorphone"
    ],
    "Specimen Type(s)": [
        "Hair (head and body)"
    ],
    "Specimen Container(s)": [
        "V-shaped aluminum foil sample holder",
        "Sample acquisition card envelope"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay (HEIA)",
        "Spectrophotometry (340 nm)",
        "Antibody competition assay"
    ],
    "Methodologies": [
        "Enzyme immunoassay",
        "Competitive binding",
        "Pre-analytical hair treatment",
        "LC/MS/MS confirmatory testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Psychemedics Homogeneous Enzyme Immunoassay for preliminary qualitative detection of opiates and oxycodone in human hair specimens",
    "Indications for Use Summary": "Preliminary qualitative detection of opiates or oxycodone in human head and body hair for identifying drug use, with LC/MS/MS as the preferred confirmatory method; intended exclusively for Psychemedics use and not for sale.",
    "fda_folder": "Toxicology"
}